Clinical Trial Update: Study Evaluation of Recombinant Hirudin in Prophylaxis of Post-Operative Deep Vein Thrombosis [Phase 4]

View source ↗

Summary

Clinical trial update on recombinant hirudin for prophylaxis of postoperative deep vein thrombosis (Phase 4).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Deep Vein Thrombosis
• Postoperative Complications

Drugs mentioned

• Recombinant Hirudin (recombinant hirudin)

Snippet

Sponsor: MinaPharm Pharmaceuticals | Conditions: Prophylaxis of Deep Vein Thrombosis | Phase 4 | Status: UNKNOWN